Location: Home
  • search
  • go
  • Relate News
  • 8/29/2023NMPA Set to Raise the Bar for Conditional Approval Process of New Drug...
  • 8/29/2023CanSino to Acquire 10% Stake in Malaysian Vaccine Maker Solution
  • 8/29/2023Mounjaro's China Approval Imminent as Domestic Competitors Enter Clini...
  • 8/28/2023Regulation of Drug and Medical Device Advertising in China: An Industr...
  • 8/28/2023Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...
  • 8/28/2023CDE Solicits Second Round Comments on Two Pharmaceutical Change Resear...
  • 8/28/2023Chinese Pharma CEOs Emphasize Strategic R&D Selection in Tough Fundrai...
  • 8/25/2023CDE Seeks Comments on Draft ICH Guidelines M7(R2)
  • 8/25/2023NMPA Issues Announcement for Applicability of ICH Guidelines Q12
  • 8/25/2023NMPA Solicits Comments on the Working Procedures for Evaluation and Ap...
  • 8/25/2023Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
  • 8/25/2023IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
  • 8/25/2023State Council Adopts New Action Plan for High-quality Development of P...
  • 8/25/2023Drug R&D and Product Registration News Digest August 2023 (4)
  • 8/25/2023China: The Latest Medtech Access Policies and Implications
  • 8/25/2023Patent Linkage in China: What the First Decisions Reveal About the Dir...
  • 8/24/2023Review of China Performance of Leading MNCs in China H1/2023 (Updated)
  • 8/24/2023Chinese Consortium Eyes Acquisition of Dominant Polish Pharma Distribu...
  • 8/24/2023CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
  • 8/23/2023NMPA Appoints New Director General of the CDE
  • 8/23/2023NMPA Issues the List of Reference Formulations for GQCE Studies (72nd ...
  • 8/23/2023Chinese and Indonesian Cos Form New Partnerships in Biotech & Healthca...
  • 8/23/2023What China's New Patent Linkage and Patent Term Extension Systems Mean...
  • 8/23/2023Increasingly, State Investment and Middle Eastern Sovereign Wealth Are...
  • 8/22/2023Patent Linkage Litigation in China: A Two-Year Review (The NLR)
  • 8/22/2023Brand-Name Drugs Feel the Squeeze in China's Generic-Heavy Market (Pod...
  • 8/22/2023CSPC, Insilico and XtalPi Sign Strategic Collaboration on AI Innovativ...
  • 8/22/2023Simcere, MabTech Inks Collaborative Agreement for CMAB009 in Mainland ...
  • 8/22/2023CDE Solicits Comments on Bioequivalence Study Guidelines of Six Generi...
  • 8/22/2023China Expands Reimbursement of Rare Disease Drugs to Improve Access: N...
  • Page:35/718 Total number of articles:21536: [First][<<] [33] [34] [35] [36] [37] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group